UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Entecavir for Treatment of Hepatitis B Virus Displays No In Vitro Mitochondrial Toxicity or DNA Polymerase Gamma Inhibition

Antimicrobial Agents and Chemotherapy, 2008-02, Vol.52 (2), p.598-605

2008

Volltextzugriff (PDF)

Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions

Journal of Virology, 2003-10, Vol.77 (19), p.10528-10536

2003

Volltextzugriff (PDF)

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Nature (London), 2010-05, Vol.465 (7294), p.96-100

2010

Volltextzugriff (PDF)

BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents

Antimicrobial Agents and Chemotherapy, 2000-08, Vol.44 (8), p.2093-2099

2000

Volltextzugriff (PDF)

Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir

Journal of medicinal chemistry, 2018-07, Vol.61 (14), p.6308-6327

2018

Volltextzugriff (PDF)

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Hepatology (Baltimore, Md.), 2006-12, Vol.44 (6), p.1656-1665

2006

Volltextzugriff (PDF)

Molecular Basis for Increased Susceptibility of Isolates with Atazanavir Resistance-Conferring Substitution I50L to Other Protease Inhibitors

Antimicrobial Agents and Chemotherapy, 2005-09, Vol.49 (9), p.3825-3832

2005

Volltextzugriff (PDF)

Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Journal of medicinal chemistry, 2014-03, Vol.57 (5), p.1708-1729

2014

Volltextzugriff (PDF)

Ultrasensitive Genotypic Detection of Antiviral Resistance in Hepatitis B Virus Clinical Isolates

Antimicrobial Agents and Chemotherapy, 2009-07, Vol.53 (7), p.2762-2772

2009

Volltextzugriff (PDF)

Effect of Antiviral Treatment with Entecavir on Age- and Dose-Related Outcomes of Duck Hepatitis B Virus Infection

Journal of Virology, 2005-05, Vol.79 (9), p.5819-5832

2005

Volltextzugriff (PDF)

Entecavir Therapy Combined with DNA Vaccination for Persistent Duck Hepatitis B Virus Infection

Antimicrobial Agents and Chemotherapy, 2003-08, Vol.47 (8), p.2624-2635

2003

Volltextzugriff (PDF)

Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)

Journal of medicinal chemistry, 2012-03, Vol.55 (5), p.2048-2056

2012

Volltextzugriff (PDF)

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

Hepatology (Baltimore, Md.), 2008-05, Vol.47 (5), p.1473-1482

2008

Volltextzugriff (PDF)

Discovery of 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions

Journal of medicinal chemistry, 2003-09, Vol.46 (20), p.4236-4239

2003

Volltextzugriff (PDF)

Utilization of in vitro Caco‐2 permeability and liver microsomal half‐life screens in discovering BMS‐488043, a novel HIV‐1 attachment inhibitor with improved pharmacokinetic properties

Journal of pharmaceutical sciences, 2010-04, Vol.99 (4), p.2135-2152

2010

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (4), p.895-901

2007

Volltextzugriff (PDF)

The effects of the Roche AMPLICOR HIV-1 MONITOR ® UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons

Journal of clinical virology, 2006-04, Vol.35 (4), p.420-425

2006

Volltextzugriff (PDF)

pH-Dependent Changes in Photoaffinity Labeling Patterns of the H1 Influenza Virus Hemagglutinin by Using an Inhibitor of Viral Fusion

Journal of Virology, 1999-03, Vol.73 (3), p.1785-1794

1999

Volltextzugriff (PDF)

Stavudine resistance: an update on susceptibility following prolonged therapy

Antiviral therapy, 1999, Vol.4 (1), p.21-28

1999

Volltextzugriff (PDF)

Stimulation of the Herpes Simplex Virus Type I Protease by Antichaeotrophic Salts (∗)

The Journal of biological chemistry, 1995-12, Vol.270 (50), p.30168-30172

1995

Volltextzugriff (PDF)

Differential effect of modified capped RNA substrates on influenza virus transcription

Virus research, 1997-07, Vol.50 (1), p.65-75

1997

Volltextzugriff (PDF)

cDNA Cloning Reveals that the Major Group Rhinovirus Receptor on HeLa Cells is Intercellular Adhesion Molecule 1

Proceedings of the National Academy of Sciences - PNAS, 1989-07, Vol.86 (13), p.4907-4911

1989

Volltextzugriff (PDF)

Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro

The Journal of biological chemistry, 1990-06, Vol.265 (16), p.9062-9065

1990

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(67)
Buchkapitel
(3)

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(48)
Humans
(35)
Biological And Medical Sciences
(30)
Pharmacology & Pharmacy
(23)
Animals
(21)
Virology
(21)
Medical Sciences
(19)
Microbiology
(18)
Antiviral Agents
(17)
Pharmacology. Drug Treatments
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)
Hiv-1 - Drug Effects
(14)
Molecular Sequence Data
(14)
Amino Acid Sequence
(13)
Antiviral Agents - Pharmacology
(10)
Chemistry, Medicinal
(10)
Infectious Diseases
(10)
Base Sequence
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Entecavir for Treatment of Hepatitis B Virus Displays No In Vitro Mitochondrial Toxicity or DNA Polymerase Gamma Inhibition

Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents

Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Molecular Basis for Increased Susceptibility of Isolates with Atazanavir Resistance-Conferring Substitution I50L to Other Protease Inhibitors

Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Ultrasensitive Genotypic Detection of Antiviral Resistance in Hepatitis B Virus Clinical Isolates

Effect of Antiviral Treatment with Entecavir on Age- and Dose-Related Outcomes of Duck Hepatitis B Virus Infection

Entecavir Therapy Combined with DNA Vaccination for Persistent Duck Hepatitis B Virus Infection

Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

Discovery of 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions

Utilization of in vitro Caco‐2 permeability and liver microsomal half‐life screens in discovering BMS‐488043, a novel HIV‐1 attachment inhibitor with improved pharmacokinetic properties

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

The effects of the Roche AMPLICOR HIV-1 MONITOR ® UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons

pH-Dependent Changes in Photoaffinity Labeling Patterns of the H1 Influenza Virus Hemagglutinin by Using an Inhibitor of Viral Fusion

Stavudine resistance: an update on susceptibility following prolonged therapy

Stimulation of the Herpes Simplex Virus Type I Protease by Antichaeotrophic Salts (∗)

Differential effect of modified capped RNA substrates on influenza virus transcription

cDNA Cloning Reveals that the Major Group Rhinovirus Receptor on HeLa Cells is Intercellular Adhesion Molecule 1

Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro

Aktive Filter

Suchergebnisse filtern